Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Scheibe

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
African Journal of Primary Health Care & Family Medicine|June 6, 2020
Harm reduction in practice - The Community Oriented Substance Use Programme in TshwaneAndrew Scheibe, Shaun Shelly, Johannes Hugo, et al.
The Lancet. Public Health|July 2, 2022
The role of low-income and middle-income country prisons in eliminating hepatitis CMatthew J Akiyama, Nadine Kronfli, Joaquin Cabezas, et al.
Hepatology, Medicine and Policy|October 6, 2018
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and accessTongai G Maponga, Rachel Matteau Matsha, Sébastien Morin, et al.
Addiction Science & Clinical Practice|February 23, 2020
Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South AfricaAndrew Scheibe, Shaun Shelly, Tara Gerardy, et al.
The International Journal on Drug Policy|October 6, 2022
Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort studyMpho Tlali, Andrew Scheibe, Yann Ruffieux, et al.
Implementation Research and Practice|November 3, 2025
Cascading Training Model to Promote Screening, Brief Intervention, and Referral to Treatment Across South Africa: Rollout in an HIV Service OrganizationKira DiClemente-Bosco, Caroline Kuo, Goodman Sibeko, et al.
The International Journal on Drug Policy|February 11, 2016
HIV prevalence and risk among people who inject drugs in five South African citiesAndrew Scheibe, David Makapela, Ben Brown, et al.
Health Science Reports|February 22, 2021
The performance of hepatitis C virus (HCV) antibody point-of-care tests on oral fluid or whole blood and dried blood spot testing for HCV serology and viral load among individuals at higher risk for HCV in South AfricaNishi Prabdial-Sing, Lucinda Gaelejwe, Lillian Makhathini, et al.
Southern African Journal of HIV Medicine|October 10, 2025
South African harm reduction guideline for chemsexAndrew Scheibe, Yolaan Andrews, Ben Brown, et al.
Harm Reduction Journal|April 13, 2019
Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional surveyAndrew Scheibe, Katherine Young, Lorraine Moses, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
African Journal of Primary Health Care & Family Medicine|June 6, 2020
Harm reduction in practice - The Community Oriented Substance Use Programme in TshwaneAndrew Scheibe, Shaun Shelly, Johannes Hugo, et al.
The Lancet. Public Health|July 2, 2022
The role of low-income and middle-income country prisons in eliminating hepatitis CMatthew J Akiyama, Nadine Kronfli, Joaquin Cabezas, et al.
Hepatology, Medicine and Policy|October 6, 2018
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and accessTongai G Maponga, Rachel Matteau Matsha, Sébastien Morin, et al.
Addiction Science & Clinical Practice|February 23, 2020
Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South AfricaAndrew Scheibe, Shaun Shelly, Tara Gerardy, et al.
The International Journal on Drug Policy|October 6, 2022
Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort studyMpho Tlali, Andrew Scheibe, Yann Ruffieux, et al.
Implementation Research and Practice|November 3, 2025
Cascading Training Model to Promote Screening, Brief Intervention, and Referral to Treatment Across South Africa: Rollout in an HIV Service OrganizationKira DiClemente-Bosco, Caroline Kuo, Goodman Sibeko, et al.
The International Journal on Drug Policy|February 11, 2016
HIV prevalence and risk among people who inject drugs in five South African citiesAndrew Scheibe, David Makapela, Ben Brown, et al.
Health Science Reports|February 22, 2021
The performance of hepatitis C virus (HCV) antibody point-of-care tests on oral fluid or whole blood and dried blood spot testing for HCV serology and viral load among individuals at higher risk for HCV in South AfricaNishi Prabdial-Sing, Lucinda Gaelejwe, Lillian Makhathini, et al.
Southern African Journal of HIV Medicine|October 10, 2025
South African harm reduction guideline for chemsexAndrew Scheibe, Yolaan Andrews, Ben Brown, et al.
Harm Reduction Journal|April 13, 2019
Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional surveyAndrew Scheibe, Katherine Young, Lorraine Moses, et al.
Pageof 5